Greenland Mines' Sarfartoq Initial Assessment Reveals Up to $2.05 Billion Pre-Tax NPV, Positioning Company as Key Non-China Rare Earth Supplier

Greenland Mines Ltd. (NASDAQ: GRML) has released an independent Initial Assessment (IA) for its Sarfartoq Nd-Pr Rare Earth Element Project in southwest Greenland, revealing a high-case pre-tax net present value (NPV) of up to approximately $2.05 billion at an 8% real discount rate, with an internal rate of return (IRR) of 118.6%, including Indicated and Inferred Mineral Resources. When excluding Inferred resources, the high-case pre-tax NPV is estimated at up to $1.49 billion with an IRR of 92.7%.

The IA outlines a nine-year mine life processing 12.2 million tons at an annual rate of 1.4 million tons. According to the company, at 2025 consumption levels, planned Sarfartoq NdPr oxide production would represent approximately 34% of NdPr oxide refined outside China during each scheduled operating year. This underscores the project's strategic importance in diversifying the global rare earth supply chain, which is currently dominated by China.

The assessment is based on the ST1 deposit, which occupies less than 1% of the company's 191-square-kilometer exploration license. Greenland Mines noted that five other known rare earth occurrences within the license remain largely untested, and the company plans to conduct additional exploration starting in September 2026. In the meantime, the company intends to carry out targeted infill drilling, pilot-scale metallurgical test work, mine engineering planning, and continued environmental and social baseline studies as it advances Sarfartoq toward a Pre-Feasibility Study.

This development is significant for the critical minerals sector, as Western nations seek to reduce reliance on Chinese rare earth exports. The Sarfartoq project's high IRR and NPV, even under conservative scenarios, suggest strong economic viability. With a relatively small footprint, the project offers potential for expansion as other occurrences are explored.

Greenland Mines is a Nasdaq-listed company with two operating divisions: Mining, focusing on the Skaergaard Project and Sarfartoq, and Biotech, including Klotho's KLTO-202 for ALS. The company's strategy is to build a multi-asset platform with exposure to rare earth magnet materials, precious metals, and midstream processing, while advancing its North Atlantic Critical Metals Corridor vision.

For more details, the full press release can be accessed at https://ibn.fm/7uEG4. Investors can also find the latest news and updates regarding GRML in the company's newsroom at https://ibn.fm/GRML.